Member Info for JohnLaw

In 2012 POW was floated under the name Sula Iron & Gold (ticker SULA) at 6p and a market cap of £1.1m It then became African Battery Metals (ABM) for a while and POW since June 2019. Any chart showing 700p for POW is either mixing in some other company that had the ticker POW at the time, or is just wrong. Sula's original project and management are long gone.

Dear Sirs
Please accept my resignation.
I don’t care to belong to any club that will have me as a member.
John Law
Lauriston Castle, Edinburgh

I don't think Vela's history is really relevant going forward now as a large part of the old investment portfolio was hived off in August 2020. The remaining rump was valued at just £586K at 30/9/20. Vela's future really begins with the Mode and SGS investments in October this year.

To qualify for the FTSE 350 TILS will need to rather more than double its market cap.
So not long then.....

I can feel the engines vibrating deep beneath the decks and ever such a slight sense of forward trajectory. Cue Rod Stewart......

Mr Benson I applaud your knowledge of the proper placing of apostrophes (not many of us left!). Many of those on this board share your impulsiveness and depth of research, so take care........

I hope so. We have to bear in mind that AAZ must have been more than a little distracted recently by the Nagorno-Karabakh war in their back garden so slow progress on the JV is understandable. I was quite appalled at the recent land-grab of the huge Armenian Sotk gold mine and do hope that AZ will not go near that for ethical reasons. I hope Gov. John Sununu will prevail in that respect on the AAZ board. Clontibret is such a sweet spot is must surely be irresistible. Get it in!

Nolupus. You have clearly not been drinking your Kool-Aid

Transfers in to my Halifax sharedealing account (from an unrelated bank) have always been literally instantaneous.

Ambivalent

Invest in sugar (I remember it too Prion)

https://www.theweek.co.uk/107269/coronavirus-polio-vaccine

how much of Rincon Resources will GUN own on IPO?
At Minimum IPO subscription 9.50%
At Maximum IPO subscription 8.55%

See page 32
https://www.rinconresources.com.au/wp-content/uploads/2020/11/Rincon-Prospectus-FINAL-03-11-20-with-Annexures-Website-Version.pdf

Dodgy Link? Sorry about that - I just tried it again (twice) both clicking and pasting and got the Tele article verbatim. Maybe its a phone thing - it did not bother my Mac. (There are some teasing pics in there that I did not explore). Don't go there!

While some funds and Investment trusts are by their constitutions limited as to what markets they can invest in I see many invested in AIM companies that I hold. I cannot find any stats on it but looking at significant shareholders of just three of the <£1 billion second tier I see Standard Life Aberdeen, BlackRock JPMorgan Asset Management Holdings, Threadneedle Asset Management, Standard Life Investments Ltd., Baillie Gifford & Co., Invesco Advisers, Inc. Legal & General Investment Management Ltd. AIM does not seem to be an impediment to these names.

I was a bit puzzled by the reasons for this as there are some 15 companies on AIM with a market cap over £1 billion and there are plenty AIM-listed companies with Nasdaq listings – many with market caps well below TILS’.

While there are many advantages to listing on AIM I could only find two* advantages (apart from the claimed “visibility”) of a main market listing which are:

1, No need to pay a Nomad and
2. No need to get shareholder approval for significant or related party transactions. (An AIM firm must get shareholder approval for transactions like reverse takeovers or disposals resulting in a fundamental change to its business).

Interesting .........

* https://www.valuethemarkets.com/2018/02/26/aim-listing-vs-standard-listing-main-market-whats-difference/

I should not post the whole article verbatim so here is an extract of salient points:
Headlines:
Questor: its niche in the booming offshore energy sector hasn’t kept Tekmar’s shares afloat
Questor share tip: the firm is a leader in protection systems for subsea cables and pipes – surely few markets are as packed with potential
ByRuss Mould December 2020
Buying at a discount to book value gives some degree of protection. - Tekmar‘s market value is £35.4m and last accounts showed net assets of £46m but large part is intangibles.

TGP performance since flotation in June 2018 is “dismal” – now 60pc below January high despite Tekmar’s leading position in the niche of protection systems for subsea cables and pipes.

Few markets are as packed with potential - Britain ‘s Green Industrial Revolution will throw money at wind power where Tekmar’s skills are likely to be in high demand.

The shares drop is in part due to contract delays. But that business is still out there and Tekmar’s launch of a new product early next year cement its competitive position.

New CEO Alasdair MacDonald, has launched a review designed to cut costs, increase efficiencies s following the departure in the summer of the founder and former boss, James Ritchie-Bland.

Net cash on the balance sheet may help it through. The next set of results is due today.
Warns about investing in smaller companies and TGP no exception.

“But the balance sheet hopefully provides some protection and there has to be a chance that a trade buyer turns up for the business at some stage, given the global momentum in the offshore renewable energy industry”
Speculative buy

Interestingly, by googling the headline I found the following link :
https://kaleistyleguide.com/investing/shares/questor-niche-booming-offshore-energy-sector-hasnt-kept-tekmars/

which may not be behind a pay wall.

I think all this means is that the Crest and non-Crest accounts shareholders' register in Accustem's OWN books will not be credited until the date announced. So while my stockbrokers are showing my Accustem holding (with a dummy price of 1p) this will not be reflected in Accustem's own books until the set date. This has no practical meaning except in the event of Accustem going bust before their books are updated. That would merely create a minor evidential issue if it ever happened but no-one would be bothering about such spilt milk anyway. The value of shares in Accustem's books is their nominal value and has no practical meaning.

Not sure what you mean by £2 funding. Accustem gets the IP and other related assets at NBV of £3.07 m + £1m cash. We are not told prior funding liabilities of TILS (if any) are transferred to Accustem. £1m may be be enough for the low ramp soft launch in Italy but I doubt it is enough for beyond that. So there will be a fund raising or partnering or sale or licensing or (unlikely) borrowing down the road. That is always the way with small pharma.

Go for it. There will be another Christmas next year.

Odey has been waived of the need to mount an offer when they when they went over 30%.
I don't know if the waiver falls if they buy any more shares but if it did they would have to make a cash offer not less than the highest price in the last 12 months.
Otherwise:
1. If SPMP lists on a convenient market we might be given shares as a distribution in kind OR
2. TSTR may just continue as a private company receiving dividends from SPMP which are passed on to us OR
3. TSTR might be bought out by an SPMP investor/3rd party OR
4. If it makes commercial sense to Odey they might buy our shares at a price that is not disadvantageous shareholders.

Nothing permits Odey to acquire our shares for peanuts.

Someone mentioned Freshwater UK. Just before delisting Freshwater had fallen to around 5.75p and spiked to 11p two days later. On its delisting there was an MBO offer to buy for cash the privately held shares for 12p or take unlisted shares in the new Hold Co, + 2p cash dividend for either option. .

An independent broker report accompanying the MBO offer that stated “Shareholders should elect to accept the Unlisted Share Alternative as we believe the Cash Offer undervalues Freshwater” (without stating what fair value was). 41% of shareholders took the cash, 54% took the shares and the balance did not respond.

I was not a holder here before last week but I am buying now. I may sell on a closing spike or hold for gold.

Why do so many think Odey will behave improperly?

an 18% increase in the price of GLIF